254 related articles for article (PubMed ID: 31267709)
101. Molecular regulation of hematopoietic stem cell quiescence.
Chen Z; Guo Q; Song G; Hou Y
Cell Mol Life Sci; 2022 Mar; 79(4):218. PubMed ID: 35357574
[TBL] [Abstract][Full Text] [Related]
102. CD150
Hirata Y; Furuhashi K; Ishii H; Li HW; Pinho S; Ding L; Robson SC; Frenette PS; Fujisaki J
Cell Stem Cell; 2018 Mar; 22(3):445-453.e5. PubMed ID: 29456159
[TBL] [Abstract][Full Text] [Related]
103. MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias.
Testa U; Pelosi E
Leuk Lymphoma; 2015 May; 56(5):1466-74. PubMed ID: 25242094
[TBL] [Abstract][Full Text] [Related]
104. Loss of bisecting GlcNAcylation on MCAM of bone marrow stoma determined pro-tumoral niche in MDS/AML.
Feng J; Wang Y; Li B; Yu X; Lei L; Wu J; Zhang X; Chen Q; Zhou Y; Gou J; Li H; Tan Z; Dai Z; Li X; Guan F
Leukemia; 2023 Jan; 37(1):113-121. PubMed ID: 36335262
[TBL] [Abstract][Full Text] [Related]
105. Scalable Enrichment of Immunomodulatory Human Acute Myeloid Leukemia Cell Line-Derived Extracellular Vesicles.
Binder HM; Maeding N; Wolf M; Cronemberger Andrade A; Vari B; Krisch L; Gomes FG; Blöchl C; Muigg K; Poupardin R; Raninger AM; Heuser T; Obermayer A; Ebner-Peking P; Pleyer L; Greil R; Huber CG; Schallmoser K; Strunk D
Cells; 2021 Nov; 10(12):. PubMed ID: 34943829
[TBL] [Abstract][Full Text] [Related]
106. tiRNA signaling via stress-regulated vesicle transfer in the hematopoietic niche.
Kfoury YS; Ji F; Mazzola M; Sykes DB; Scherer AK; Anselmo A; Akiyama Y; Mercier F; Severe N; Kokkaliaris KD; Zhao T; Brouse T; Saez B; Seidl J; Papazian A; Ivanov P; Mansour MK; Sadreyev RI; Scadden DT
Cell Stem Cell; 2021 Dec; 28(12):2090-2103.e9. PubMed ID: 34551362
[TBL] [Abstract][Full Text] [Related]
107. A mitochondrial NADPH-cholesterol axis regulates extracellular vesicle biogenesis to support hematopoietic stem cell fate.
Bonora M; Morganti C; van Gastel N; Ito K; Calura E; Zanolla I; Ferroni L; Zhang Y; Jung Y; Sales G; Martini P; Nakamura T; Lasorsa FM; Finkel T; Lin CP; Zavan B; Pinton P; Georgakoudi I; Romualdi C; Scadden DT; Ito K
Cell Stem Cell; 2024 Mar; 31(3):359-377.e10. PubMed ID: 38458178
[TBL] [Abstract][Full Text] [Related]
108. A Proteomic Approach to Understand the Clinical Significance of Acute Myeloid Leukemia-Derived Extracellular Vesicles Reflecting Essential Characteristics of Leukemia.
Kang KW; Kim H; Hur W; Jung JH; Jeong SJ; Shin H; Seo D; Jeong H; Choi B; Hong S; Kim HK; Choi Y; Park JH; Lee KY; Kim KP; Park Y
Mol Cell Proteomics; 2021; 20():100017. PubMed ID: 33592500
[TBL] [Abstract][Full Text] [Related]
109. Author Correction: Quiescence enables unrestricted cell fate in naive embryonic stem cells.
Khoa LTP; Yang W; Shan M; Zhang L; Mao F; Zhou B; Li Q; Malcore R; Harris C; Zhao L; Rao RC; Iwase S; Kalantry S; Bielas SL; Lyssiotis CA; Dou Y
Nat Commun; 2024 Mar; 15(1):2215. PubMed ID: 38472240
[No Abstract] [Full Text] [Related]
110. Hematopoietic stem and progenitor cell signaling in the niche.
Hurwitz SN; Jung SK; Kurre P
Leukemia; 2020 Dec; 34(12):3136-3148. PubMed ID: 33077865
[TBL] [Abstract][Full Text] [Related]
111. Extracellular Vesicles and Chemotherapy Resistance in the AML Microenvironment.
Nehrbas J; Butler JT; Chen DW; Kurre P
Front Oncol; 2020; 10():90. PubMed ID: 32117744
[TBL] [Abstract][Full Text] [Related]
112. Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia.
Bernardi S; Foroni C; Zanaglio C; Re F; Polverelli N; Turra A; Morello E; Farina M; Cattina F; Gandolfi L; Zollner T; Buttini EA; Malagola M; Russo D
Int J Mol Med; 2019 Dec; 44(6):2133-2144. PubMed ID: 31638195
[TBL] [Abstract][Full Text] [Related]
113. Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche.
Chen DW; Fan JM; Schrey JM; Mitchell DV; Jung SK; Hurwitz SN; Perez EB; Muraro MJ; Carroll M; Taylor DM; Kurre P
Leukemia; 2024 Apr; 38(4):741-750. PubMed ID: 38228679
[TBL] [Abstract][Full Text] [Related]
114. Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia.
Sharma P; Borthakur G
Cancer Drug Resist; 2023; 6(3):567-589. PubMed ID: 37842232
[TBL] [Abstract][Full Text] [Related]
115. Regulation of hematopoietic stem cells differentiation, self-renewal, and quiescence through the mTOR signaling pathway.
Ling B; Xu Y; Qian S; Xiang Z; Xuan S; Wu J
Front Cell Dev Biol; 2023; 11():1186850. PubMed ID: 37228652
[TBL] [Abstract][Full Text] [Related]
116. Extracellular Vesicles in Breast Cancer: From Biology and Function to Clinical Diagnosis and Therapeutic Management.
Loric S; Denis JA; Desbene C; Sabbah M; Conti M
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108371
[TBL] [Abstract][Full Text] [Related]
117. Bone marrow-derived extracellular vesicles carry the TGF-β signal transducer Smad2 to preserve hematopoietic stem cells in mice.
Gautheron F; Georgievski A; Garrido C; Quéré R
Cell Death Discov; 2023 Apr; 9(1):117. PubMed ID: 37019878
[TBL] [Abstract][Full Text] [Related]
118. Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases.
Li G; Chen T; Dahlman J; Eniola-Adefeso L; Ghiran IC; Kurre P; Lam WA; Lang JK; Marbán E; Martín P; Momma S; Moos M; Nelson DJ; Raffai RL; Ren X; Sluijter JPG; Stott SL; Vunjak-Novakovic G; Walker ND; Wang Z; Witwer KW; Yang PC; Lundberg MS; Ochocinska MJ; Wong R; Zhou G; Chan SY; Das S; Sundd P
J Extracell Vesicles; 2023 Feb; 12(2):e12305. PubMed ID: 36775986
[TBL] [Abstract][Full Text] [Related]
119. Emerging roles of extracellular vesicles in normal and malignant hematopoiesis.
Sun G; Gu Q; Zheng J; Cheng H; Cheng T
J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 36106632
[TBL] [Abstract][Full Text] [Related]
120. Extracellular Vesicles in Myeloid Neoplasms.
Karantanou C; Minciacchi VR; Karantanos T
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
